[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @PracticalNeuro Practical Neurology Practical Neurology posts on X about $abbv, people with, medtronic, X months the most. They currently have XXXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours. ### Engagements: XX [#](/creator/twitter::386755226/interactions)  - X Week XXXXX +39% - X Month XXXXXX +1,194% - X Months XXXXXX +24% - X Year XXXXXX +91% ### Mentions: X [#](/creator/twitter::386755226/posts_active)  ### Followers: XXXXXX [#](/creator/twitter::386755226/followers)  - X Week XXXXXX +0.21% - X Month XXXXXX +0.92% - X Months XXXXXX +4.10% - X Year XXXXXX +7% ### CreatorRank: undefined [#](/creator/twitter::386755226/influencer_rank)  ### Social Influence [#](/creator/twitter::386755226/influence) --- **Social category influence** [stocks](/list/stocks) XXXXX% **Social topic influence** [$abbv](/topic/$abbv) #63, [people with](/topic/people-with) #461, [medtronic](/topic/medtronic) 3.7%, [6 months](/topic/6-months) 3.7%, [longterm](/topic/longterm) XXX% **Top accounts mentioned or mentioned by** [@aanmember](/creator/undefined) [@mssociety](/creator/undefined) [@ectrims](/creator/undefined) [@movedisorder](/creator/undefined) [@michaeljfoxorg](/creator/undefined) [@mscare](/creator/undefined) [@novartis](/creator/undefined) [@ahsheadache](/creator/undefined) [@acpimphysicians](/creator/undefined) [@aanemorg](/creator/undefined) [@abbvie](/creator/undefined) [@nhf](/creator/undefined) [@amfmigraine](/creator/undefined) [@alzassociation](/creator/undefined) [@boveriley](/creator/undefined) [@ucsf](/creator/undefined) [@reachmd](/creator/undefined) [@theneurologyhub](/creator/undefined) [@usfda](/creator/undefined) [@medtronic](/creator/undefined) **Top assets mentioned** [AbbVie Inc (ABBV)](/topic/$abbv) [Medtronic PLC (MDT)](/topic/medtronic) ### Top Social Posts [#](/creator/twitter::386755226/posts) --- Top posts by engagements in the last XX hours "The @US_FDA has approved #Altaviva (@Medtronic) an implantable #neuromodulation device designed to treat urge urinary incontinence a symptom that can be associated with conditions like #Parkinsons #Multiple_Sclerosis #Stroke and more. @AANmember @ACPIMPhysicians" [X Link](https://x.com/PracticalNeuro/status/1970941648679973318) [@PracticalNeuro](/creator/x/PracticalNeuro) 2025-09-24T20:01Z 18K followers, XXX engagements "#Botox treatment improved functional outcomes in people with upper limb essential #tremor vs placebo according to study results presented at #MDS2025. @movedisorder @MichaelJFoxOrg @essentialtremor @AbbVie" [X Link](https://x.com/PracticalNeuro/status/1977373983470223758) [@PracticalNeuro](/creator/x/PracticalNeuro) 2025-10-12T14:01Z 18K followers, 1881 engagements "People with advanced idiopathic #Parkinson disease treated with #Foslevodopa/#Foscarbidopa showed improvements in motor and non-motor symptoms at X months in a study presented at #MDS2025. #Vyalev @AbbVie @Movedisorder @MichaelJFoxOrg" [X Link](https://x.com/PracticalNeuro/status/1977706376622223511) [@PracticalNeuro](/creator/x/PracticalNeuro) 2025-10-13T12:01Z 18K followers, XXX engagements "Treatment with #Ultomiris (#ravulizumab) for those with #NMOSD was associated with long-term relapse prevention in data presented at #ECTRIMS2025. @ECTRIMS @AlexionPharma @AstraZeneca @mssociety" [X Link](https://x.com/PracticalNeuro/status/1974565347102433696) [@PracticalNeuro](/creator/x/PracticalNeuro) 2025-10-04T20:00Z 18K followers, 1149 engagements "Results from phase X #NIMBLE trial: @Regeneron announces #cemdisiran monotherapy significantly improved MG-ADL and QMG scores in adults with generalized #Myasthenia_Gravis vs placebo. @MyastheniaOrg @AANEMorg @mssociety" [X Link](https://x.com/PracticalNeuro/status/1963723908357525537) [@PracticalNeuro](/creator/x/PracticalNeuro) 2025-09-04T22:00Z 18K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Practical Neurology posts on X about $abbv, people with, medtronic, X months the most. They currently have XXXXXX followers and XX posts still getting attention that total XX engagements in the last XX hours.
Social category influence stocks XXXXX%
Social topic influence $abbv #63, people with #461, medtronic 3.7%, 6 months 3.7%, longterm XXX%
Top accounts mentioned or mentioned by @aanmember @mssociety @ectrims @movedisorder @michaeljfoxorg @mscare @novartis @ahsheadache @acpimphysicians @aanemorg @abbvie @nhf @amfmigraine @alzassociation @boveriley @ucsf @reachmd @theneurologyhub @usfda @medtronic
Top assets mentioned AbbVie Inc (ABBV) Medtronic PLC (MDT)
Top posts by engagements in the last XX hours
"The @US_FDA has approved #Altaviva (@Medtronic) an implantable #neuromodulation device designed to treat urge urinary incontinence a symptom that can be associated with conditions like #Parkinsons #Multiple_Sclerosis #Stroke and more. @AANmember @ACPIMPhysicians"
X Link @PracticalNeuro 2025-09-24T20:01Z 18K followers, XXX engagements
"#Botox treatment improved functional outcomes in people with upper limb essential #tremor vs placebo according to study results presented at #MDS2025. @movedisorder @MichaelJFoxOrg @essentialtremor @AbbVie"
X Link @PracticalNeuro 2025-10-12T14:01Z 18K followers, 1881 engagements
"People with advanced idiopathic #Parkinson disease treated with #Foslevodopa/#Foscarbidopa showed improvements in motor and non-motor symptoms at X months in a study presented at #MDS2025. #Vyalev @AbbVie @Movedisorder @MichaelJFoxOrg"
X Link @PracticalNeuro 2025-10-13T12:01Z 18K followers, XXX engagements
"Treatment with #Ultomiris (#ravulizumab) for those with #NMOSD was associated with long-term relapse prevention in data presented at #ECTRIMS2025. @ECTRIMS @AlexionPharma @AstraZeneca @mssociety"
X Link @PracticalNeuro 2025-10-04T20:00Z 18K followers, 1149 engagements
"Results from phase X #NIMBLE trial: @Regeneron announces #cemdisiran monotherapy significantly improved MG-ADL and QMG scores in adults with generalized #Myasthenia_Gravis vs placebo. @MyastheniaOrg @AANEMorg @mssociety"
X Link @PracticalNeuro 2025-09-04T22:00Z 18K followers, XXX engagements
/creator/twitter::PracticalNeuro